Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achaogen Inc AKAOQ

Healthcare Biotechnology
"Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is... see more

Recent & Breaking News (OTCPK:AKAOQ)

Achaogen, Inc. Announces Results of Auction for Substantially All Company Assets

GlobeNewswire June 6, 2019

Achaogen Plans for Near-Term Sale Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

GlobeNewswire April 15, 2019

The Daily Biotech Pulse: Safety Board Clears Eisai's Alzheimer's Study, Positive Trial Results For Galapagos-Gilead

Benzinga.com  March 29, 2019

The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO

Benzinga.com  March 28, 2019

Earnings Scheduled For March 28, 2019

Benzinga.com  March 28, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Benzinga.com  March 23, 2019

The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering

Benzinga.com  March 14, 2019

The Daily Biotech Pulse: Zafgen Won't File IND For Metabolic Disorder Drug, Positive Results For Akebia's Anemia Drug

Benzinga.com  March 12, 2019

The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis

Benzinga.com  March 1, 2019

The Daily Biotech Pulse: Genomic Health Earnings, AbbVie's Humira Approved For Another Indication In Japan

Benzinga.com  February 21, 2019

Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences

GlobeNewswire February 20, 2019

The Daily Biotech Pulse: Acorda Swings To Profit, Achaogen Offering, Bioblast Strikes Sanfilippo Syndrome Deal

Benzinga.com  February 15, 2019

Achaogen Announces Pricing of $15 Million Underwritten Public Offering

GlobeNewswire February 15, 2019

Achaogen Announces Proposed Public Offering of Common Stock

GlobeNewswire February 14, 2019

Achaogen Provides Update on Corporate Progress and Key Preliminary Fourth Quarter 2018 Results

GlobeNewswire February 14, 2019

Achaogen Submits Response to ASPR/BARDA Request for Information (RFI) for Antimicrobial Resistance Project BioShield

GlobeNewswire February 14, 2019

Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin Immunoassay

GlobeNewswire December 10, 2018

The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut

Benzinga.com  December 7, 2018

The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering

Benzinga.com  December 6, 2018

Recent Analysis Shows Best Buy Co., News Corporation, Semtech, Achaogen, Infosys, and Galapagos NV Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire December 6, 2018